WallStreetZenWallStreetZen

NASDAQ: BCDA
Biocardia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BCDA stock forecasts and price targets.

Forecast return on equity

Is BCDA forecast to generate an efficient return?

Forecast return on assets

Is BCDA forecast to generate an efficient return on assets?

Company
-286.03%
Industry
47.72%
BCDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BCDA earnings per share forecast

What is BCDA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.22

BCDA revenue forecast

What is BCDA's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.0k
Avg 2 year Forecast
$100.0k
Avg 3 year Forecast
$100.0k

BCDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCDA$2.14N/AN/A
LPTX$0.30N/AN/A
MRKR$0.96$12.50+1,208.90%Strong Buy
PHIO$2.18$10.67+389.31%Buy
SNGX$2.92$6.00+105.48%Strong Buy
View Top Biotech Stocks

Biocardia Stock Forecast FAQ

What is BCDA's earnings growth forecast for 2025-2025?

(NASDAQ: BCDA) Biocardia's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.29%.

Biocardia's earnings in 2025 is -$8,794,000.

In 2025, BCDA is forecast to generate -$7,077,493 in earnings, with the lowest earnings forecast at -$7,077,493 and the highest earnings forecast at -$7,077,493.

If you're new to stock investing, here's how to buy Biocardia stock.

What is BCDA's revenue growth forecast for 2025-2027?

(NASDAQ: BCDA) Biocardia's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Biocardia's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast BCDA's revenue for 2025 to be $580,122, with the lowest BCDA revenue forecast at $580,122, and the highest BCDA revenue forecast at $580,122. On average, 1 Wall Street analysts forecast BCDA's revenue for 2026 to be $580,122, with the lowest BCDA revenue forecast at $580,122, and the highest BCDA revenue forecast at $580,122.

In 2027, BCDA is forecast to generate $580,122 in revenue, with the lowest revenue forecast at $580,122 and the highest revenue forecast at $580,122.

What is BCDA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BCDA) forecast ROA is -286.03%, which is lower than the forecast US Biotechnology industry average of 47.72%.

What is BCDA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: BCDA) Biocardia's current Earnings Per Share (EPS) is -$1.85. In 2025, BCDA's EPS is forecast to hit -$1.22 (min: -$1.22, max: -$1.22).

What is BCDA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BCDA) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.